Consequently, research into the mechanisms underlying TCM may provide novel directions for future AR treatment strategies
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CT-996 in Overweight/Obese Participants and in Patients With Type 2 Diabetes Mellitus [Internet
Tirzepatide (Mounjaro) targets GLP-1 and GIP receptors with weight loss of approximately 20-22%
Furthermore, in three previous RCTs of non-pregnant hypertensive patients, with and without CVD, we demonstrated that intervention with low-dose riboflavin (16 mg/d) for 16 weeks resulted in a lowering of systolic blood pressure by up to 13 mmHg, specifically in those with the TT genotype (Reference Horigan, McNulty and Ward112Reference Wilson, Mcnulty and Ward114)
They stimulate the release of insulin and suppress the release of glucagon, another hormone, to help control blood sugar levels, and they also reduce appetite and delay gastric emptying to aid in weight reduction
